[HTML][HTML] COVID-19 immunobiology: lessons learned, new questions arise

A Kaklamanos, K Belogiannis, P Skendros… - Frontiers in …, 2021 - frontiersin.org
There is strong evidence that COVID-19 pathophysiology is mainly driven by a
spatiotemporal immune deregulation. Both its phenotypic heterogeneity, spanning from …

[HTML][HTML] Immune response, inflammation, and the clinical spectrum of COVID-19

LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …

[HTML][HTML] The intersection of COVID-19 and autoimmunity: What is our current understanding?

N Winchester, C Calabrese… - Pathogens and Immunity, 2021 - ncbi.nlm.nih.gov
Viral infections have historically had a complex relationship with autoimmune diseases. For
patients with preexisting autoimmune disorders, often complicated by immunosuppressive …

Humoral immune mechanisms involved in protective and pathological immunity during COVID-19

G Widjaja, AT Jalil, HS Rahman, WK Abdelbasset… - Human Immunology, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 is
associated with excessive inflammation, as a main reason for severe condition and death …

[HTML][HTML] The immune response to SARS-CoV-2 and COVID-19 immunopathology–current perspectives

JL Boechat, I Chora, A Morais, L Delgado - Pulmonology, 2021 - Elsevier
SARS-CoV-2 is a new beta coronavirus, similar to SARS-CoV-1, that emerged at the end of
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …

[HTML][HTML] The immune response and immunopathology of COVID-19

E Mortaz, P Tabarsi, M Varahram, G Folkerts… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses were first discovered in the 1960s and are named due to their crown-like
shape. Sometimes, but not often, a coronavirus can infect both animals and humans. An …

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview

LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …

[HTML][HTML] Mechanistic insights into the immune pathophysiology of COVID-19; an in-depth review

A Shafqat, S Shafqat, SA Salameh, J Kashir… - Frontiers in …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which causes
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …

[HTML][HTML] Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention

DR Sweet, ML Freeman, DA Zidar - Pathogens and Immunity, 2023 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) has had profound effects on the health of
individuals and on healthcare systems worldwide. While healthcare workers on the …

[HTML][HTML] Hallmarks of severe COVID-19 pathogenesis: A pas de deux between viral and host factors

R Rovito, M Augello, A Ben-Haim, V Bono… - Frontiers in …, 2022 - frontiersin.org
Two years into Coronavirus Disease 2019 (COVID-19) pandemic, a comprehensive
characterization of the pathogenesis of severe and critical forms of COVID-19 is still missing …